Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
64,97 USD | +0,02% | -.--% | +240,87% |
Omzet 2022 | 30,06 mln. 28,04 mln. | Omzet 2023 | 58,88 mln. 54,92 mln. | Marktkapitalisatie | 1,11 mld. 1,03 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -57 mln. -53,17 mln. | Nettowinst (verlies) 2023 | -32 mln. -29,85 mln. | EV/omzet 2022 | 3,79 x |
Nettoliquiditeiten 2022 | 223 mln. 208 mln. | Nettoliquiditeiten 2023 | 317 mln. 296 mln. | EV/omzet 2023 | 13,4 x |
K/w-verhouding 2022 |
-4,25
x | K/w-verhouding 2023 |
-29,6
x | Werknemers | 142 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 96,04% |
Recentste transcriptie over Alpine Immune Sciences, Inc.
1 dag | +0,02% | ||
1 maand | +0,03% | ||
3 maanden | +77,47% | ||
6 maanden | +245,40% | ||
Lopend jaar | +240,87% |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.64% | 4 M€ | -5,15% | - | |
0.02% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - | |
0.00% | 9 M€ | +10,39% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+240,87% | 4,46 mld. | |
+17,73% | 124 mld. | |
+16,88% | 111 mld. | |
-9,04% | 23,17 mld. | |
+4,40% | 22,94 mld. | |
-38,15% | 17,42 mld. | |
-7,75% | 17,42 mld. | |
-15,36% | 16,9 mld. | |
+3,42% | 13,71 mld. | |
+29,63% | 11,82 mld. |